From
StayCurrentMD
Inflammatory Bowel Disease: Update Course 2015
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Video
Inflammatory Bowel Disease: Update Course 2014
28 min · Published Sep 2014
Video
Inflammatory Bowel Disease (IBD) - Samir Pandya: Update Course 2014
28 min · Published Nov 2018
Video
Enhanced Recovery After Surgery (ERAS) Program: Update Course 2016
44 min · Published Jul 2017
Video
Best of the Best Gen Surg - Therapeutic Effect of Oridonin against Inflammatory Bowel Disease Involves Inhibition of Intestinal Fibrosis via NF-kB and p38STAT1 Pathways - Dr. Mao
11 min · Published Sep 2022
Video
ERAS - Clinical Practice Updates
Published Sep 2020
Podcast
Journal of Pediatric Surgery Article Review: December 2023
15 min · Published May 2024
Video
Intestinal Atresia Types Explained: Grossfeld Classification for Pediatric Surgery
1 min · Published Sep 2026
Video
Derivation and validation of the Pediatric Community-Acquired Pneumonia Severity (PedCAPS) score: A prospective cohort study
50 s · Published Sep 2026
Video
FETO for Late-Diagnosed Severe Congenital Diaphragmatic Hernia (CDH) at Cincinnati Children's with Dr. Beth Rymeski
4 min · Published Sep 2026
Video
Severe Congenital Diaphragmatic Hernia (CDH) Case: FETO Management & Unexpected Findings with Dr. Beth Rymeski
3 min · Published Sep 2026
Video
Fetoscopic Endoluminal Tracheal Occlusion (FETO) Procedure: Step-by-Step Guide with Dr. Beth Rymeski
4 min · Published Sep 2026
Video
Choledochal Cyst Types Explained: Pediatric Surgery Fundamentals
1 min · Published Sep 2026
What the experts said
For Crohn's disease with terminal ileum stricture and phlegmonous changes encasing the ureter, laparoscopic ileocystectomy with a lighted ureteral stent for ureter identification is the appropriate surgical approach.
If the patient is stable, giving a couple weeks of antibiotics to cool down inflammation before surgery is advisable in Crohn's disease.
There is no data to support the exact timing of preoperative antibiotics in Crohn's disease.
Based on small literature, surgery should be delayed 2-4 weeks from the last TNF inhibitor infusion preoperatively if possible.
Postoperatively, TNF inhibitor can be restarted after about 2 weeks if active disease is seen in other parts of the bowel, or after 4 weeks if disease is less aggressive.
The literature on anastomotic complications with TNF inhibitors is mixed; wound complications are the biggest concern in the literature.
The decision to perform single-stage versus diverted J-pouch reconstruction depends on intraoperative findings including ease of pouch creation, tissue health, and presence of tension.
Patients on steroids and infliximab have risk factors for anastomotic complications.
Surgery for ulcerative colitis may be indicated when complications of medical therapy (long-term side effects of anti-TNF drugs, steroids, growth failure) become intolerable, even if the disease is controlled.
Only about 20% of patients with ulcerative colitis develop colon cancer by 20 years from the time of original diagnosis.
Patients with ulcerative colitis can live their entire life with their colons if they undergo yearly surveillance colonoscopy; there is no reason to have a colectomy without other indications beyond cancer risk alone.
For indeterminate colitis with patchy disease throughout the colon, the conservative approach is to divert with ileostomy and observe what happens to the colon.
For indeterminate colitis with extensively diseased colon, one would consider subtotal colectomy with ileostomy to obtain a large specimen for pathologic determination of disease type.
There is literature on doing total proctocolectomy and J-pouch for indeterminate colitis, but it carries more risk.
Performing a J-pouch in a patient who turns out to have Crohn's disease creates significant challenges.
Thin asthenic females with indeterminate colitis do not do well with J-pouch.
A stepwise approach to J-pouch in indeterminate colitis allows time to obtain more diagnostic information between stages.
J-pouch is a procedure with a definite learning curve in terms of technical aspects.
In pediatric patients, the rectum can be divided laparoscopically, everted or stapled across at the columns, then the J-pouch created externally with anvil placement for EEA anastomosis, as an alternative to the adult technique.
J-pouch provides the best operation for control of bowel issues in ulcerative colitis patients, and patients can still carry pregnancies even if natural conception is impaired.
In Sweden, 50% of facilities are doing ileorectal anastomosis instead of ileal pouch-anal anastomosis due to concerns about infertility in females.
Infertility rates after J-pouch are as high as 60% in some series.
The infertility rate in the United States general population is around 10-11%.
Infertility rate after laparoscopic J-pouch procedures is about 20-30%, compared to 50-60% with open procedures.
Fecundity rate (ability to carry a pregnancy) is the same after J-pouch; patients may need assistance with conception but can carry pregnancies.
In some European practices, performing a pull-through operation on a patient before the end of their childbearing years is considered unacceptable.
It is no longer necessarily true that the colon must be removed in all ulcerative colitis patients; surveillance colonoscopy is an acceptable alternative.
Some surgeons perform total proctocolectomy with J-pouch reconstruction in selected Crohn's patients with good results, as presented in adult literature.
